Biological age has become one of the most searched wellness terms of the past year, largely on the promise that a single number can tell you how fast your body is aging compared with everyone else born the same year. The idea is real and backed by legitimate research. Its marketing, as a simple age you can buy down with a supplement stack, is mostly not.
Here is what biological age testing actually measures, the two very different ways to get a number, and what the research says about whether that number can move.
Chronological Age Versus Biological Age
Chronological age is just a count of years since birth. Biological age is an estimate of how much wear a body has accumulated relative to that count, built from measurable markers rather than a birth certificate. Two 50-year-olds can have meaningfully different biological ages depending on genetics, disease history, and lifestyle exposures over time.
That distinction matters because chronological age is fixed and biological age, at least in theory, is not. That is the premise the entire testing industry is built on.
Two Different Ways to Measure It
The first and most-discussed approach is the epigenetic clock, which reads DNA methylation patterns, chemical tags attached to DNA that shift in predictable ways as cells age. Early clocks like Horvath's 2013 model estimated chronological age from methylation data with notable accuracy. Newer clocks go further: DunedinPACE, developed from two decades of data on a single birth cohort, does not estimate a static age at all. It measures the pace of aging, how fast a person's organ systems are declining right now relative to a normal one-year rate, which researchers say better predicts disease and mortality risk than a snapshot age does. TruDiagnostic's TruAge test, one of the more widely used consumer options, runs DunedinPACE alongside two other proprietary clocks from a finger-stick blood sample collected at home and mailed in, sold through both individual purchase and provider ordering. Practitioners who work in Fullscript can now order it from there, since TruDiagnostic's epigenetic testing, including the TruAge + TruHealth test, sits in the platform's labs catalog next to its standard blood panels.
The second approach skips DNA methylation and works from routine blood chemistry instead. Phenotypic Age, developed by Morgan Levine and colleagues at Yale in 2018 and validated against national health survey data, calculates a biological age estimate from nine standard biomarkers: albumin, creatinine, fasting glucose, C-reactive protein, lymphocyte percentage, mean cell volume, red blood cell distribution width, alkaline phosphatase, and white blood cell count. Every one of those markers shows up on bloodwork many providers already order as part of a standard metabolic and complete blood count panel, which means a version of this calculation does not necessarily require a specialty test at all, just the formula applied to results a provider can already pull.
Neither approach gives an identical number, and they are measuring related but distinct things: methylation clocks read a cellular-level aging signature, while phenotypic age reflects how organ systems are functioning right now. Providers who work with both tend to treat DNA methylation results as the more research-validated marker of long-term aging trajectory and phenotypic age as a useful, more accessible proxy drawn from labs a person may already have.
Can the Number Actually Move?
The most direct evidence that biological age can shift comes from a small randomized controlled trial published in the journal Aging in 2021. Researchers assigned 43 healthy men ages 50 to 72 to either an eight-week program combining dietary changes, sleep guidance, exercise, relaxation practice, and specific probiotic and phytonutrient supplementation, or to no intervention. Epigenetic age in the treatment group, measured by the Horvath clock, came in 3.23 years lower than the control group's by the end of the study, a between-group difference that reached statistical significance. "We showed a significant reversal of biological age in our subjects by 3.23 years as compared to the control group," said Kara Fitzgerald, the study's lead author, describing the topline result in an interview with the journal's publisher. Within the treatment group alone, the drop from baseline was smaller and only trended toward significance, a distinction worth sitting with before treating the headline number as settled science.
This was a pilot study of 43 men, not a large or diverse trial, and the researchers themselves described it as the first study of its kind rather than a final word. Fitzgerald herself has framed it the same way: "this was our pilot study and we'd like to do a longer study, a larger study with men and women." It is genuine evidence that lifestyle intervention can move a methylation-based age marker over a matter of weeks. It is not evidence that any specific supplement in that stack, taken alone, produces the same result, and it says nothing about whether the change holds up over years rather than two months.
What This Means in Practice
For someone deciding whether biological age testing is worth pursuing, the practical split is this: a DNA methylation test like TruAge gives the more research-backed signal on aging pace but requires a dedicated kit and cost. A phenotypic age calculation works from biomarkers that may already be sitting in a recent blood panel, which makes it a reasonable starting point before paying for a specialty test.
Whichever method someone starts with, the number itself is only useful if it changes what happens next, not as a score to check once and forget.